Key result
Statin adherence drops below 60% post-infarction, driving higher rates of major cardiovascular events.
Answers are grounded in this paper and cite their sources.
Shows that declining statin adherence increases major adverse cardiovascular events after myocardial and cerebral infarction, highlighting the need for improved patient education.
As the secondary preventive drug for cardiovascular and cerebrovascular diseases, statins can significantly improve the prognosis of patients with myocardial infarction and cerebral infarction. However, the investigations on the application of statins showed that statin withdrawal and dose reduction are very common in patients with acute myocardial infarction and cerebral infarction. After 6 months of treatment, patients with good adherence were less than 60%. With the prolongation of treatment time, the proportion of patients with poor adherence or discontinued treatment gradually increased. The decline of adherence to statin therapy was related to many factors, such as patients′ concern about drug safety, insufficient communication between doctors and patients, excessive combination of drugs, and economic status and educational levels of patients. Adherence to statin therapy could affect markedly the prognosis of atherosclerotic cardiovascular disease and poor statin adherence could increase the incidence of major adverse cardiovascular events. It is necessary to improve the physician′ awareness of importance of statin therapy, strengthen the education of medication adherence, rationally select treatment drugs, monitor adverse drug reactions, and enhance patients′ adherence to statin therapy.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2018) conducted a review in Myocardial infarction and cerebral infarction. Statin therapy adherence vs. Poor statin adherence, withdrawal, or dose reduction was evaluated on Major adverse cardiovascular events and prognosis of atherosclerotic cardiovascular disease. Statin adherence falls below 60% after 6 months in myocardial or cerebral infarction patients, with poor adherence increasing the incidence of major adverse cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: